Ichthyosis, Lamellar clinical trials
The registry lists 7 studies for Ichthyosis, Lamellar across more than 10 countries. 1 are recruiting or about to start. 5 of them are mainly about Ichthyosis, Lamellar (how this is decided). Per ClinicalTrials.gov, last updated 2026-06-17.
Get an email when these change. Save the Ichthyosis, Lamellar studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Who runs them
Centre Hospitalier Universitaire de Nice (1) · National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) (1) · Assistance Publique - Hôpitaux de Paris (1) · Northwestern University (1) · National Cancer Institute (NCI) (1) · Mayne Pharma International Pty Ltd (1) · Stiefel, a GSK Company (1)
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
The study
- Oct 2027Lymphocyte Phenotype of Autosomal Recessive Congenital Ichthyoses Mutated NIPAL4 (Nipal4-nEDD) · Assistance Publique - Hôpitaux de Paris
Who these studies take
No Ichthyosis, Lamellar study is recruiting now.
Across all 7 studies, recruiting or not: 0% stop at 75 or younger and 0% at 65; 71% take children; 0% are for women only and 0% for men only; 14% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
Studies
Recruiting first, then most recently updated. Showing 7 of 7. search them.
- Lymphocyte Phenotype of Autosomal Recessive Congenital Ichthyoses Mutated NIPAL4 (Nipal4-nEDD)Not yet recruitingNCT07477769
- Treatment of the Recessive Nonbullous Congenital Ichthyosis by the Epigallocatechine CutaneousCompletedNCT01222000Phase 31 country
- A Safety, Efficacy and Systemic Exposure Study of CD5789 Cream in Adults and Adolescents With Lamellar IchthyosisTerminatedNCT03738800Phase 29 countries
- National Registry for Ichthyosis and Related DisordersCompletedNCT000746851 country
- The Efficacy and Safety of Secukinumab in Patients With IchthyosesCompletedNCT03041038Phase 21 country
- Efficacy and Safety of Two Doses of Liarozole vs. Placebo for the Treatment of Lamellar IchthyosisCompletedNCT00282724Phase 2/39 countries
- Study of Scaling Disorders and Other Inherited Skin DiseasesCompletedNCT000012921 country